ONCY

#3427
Oncolytics Biotech Inc. - Common Stock
1.0 4 USD
+10.64%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.04
1.04
Intervallo Annuale
0.33
1.51
Variazione giornaliera
+10.64%
Variazione Mensile
+14.29%
Variazione di 6 mesi
+4.00%
Variazione Annuale
+173.68%
Chiusura Precedente
0.9 4
Open
1.0 4
Minimo
1.0 4
High
1.0 4
Volume
30
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q4, 25Q1, 26 TTM

Oncolytics Biotech Inc. - Common Stock

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Notizie